🇺🇸 FDA
Pipeline program

OD-07656

OD-07656-001

Phase 1 small_molecule completed

Quick answer

OD-07656 for Inflammatory Bowel Diseases is a Phase 1 program (small_molecule) at Odyssey Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Odyssey Therapeutics
Indication
Inflammatory Bowel Diseases
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials